Sumatriptan and Ranexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan and Ranexa. Common interactions include headache among females and apnoea among males.

The phase IV clinical study analyzes what interactions people who take Sumatriptan and Ranexa have. It is created by eHealthMe based on reports of 8 people who take Sumatriptan and Ranexa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

8 people who take Sumatriptan and Ranexa together, and have interactions are studied.


What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 12,911 Sumatriptan users for its effectiveness, alternative drugs and more.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,089 Ranexa users for its effectiveness, alternative drugs and more.

Number of Sumatriptan and Ranexa reports submitted per year:

Sumatriptan and Ranexa drug interactions.

Common Sumatriptan and Ranexa drug interactions by gender *:

female:

  1. Headache
  2. Abdominal pain upper
  3. Akathisia
  4. Ankle fracture
  5. Asthenia
  6. Breast cyst
  7. Bronchitis
  8. Burns third degree
  9. Cardiac disorder
  10. Chills

male:

  1. Apnoea
  2. Cerebrovascular accident
  3. Stent placement
  4. Wheezing
  5. Cluster headache
  6. Cough
  7. Dyspnoea
  8. Obesity
  9. Peripheral vascular disorder
  10. Pulmonary mass

Common Sumatriptan and Ranexa drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain upper
  2. Cardiac disorder
  3. Chills
  4. Diarrhoea
  5. Headache
  6. Insomnia
  7. Malaise
  8. Nausea
  9. Photopsia
  10. Pyrexia

50-59:

n/a

60+:

  1. Somnolence
  2. Akathisia
  3. Cough
  4. Dyspnoea
  5. Emotional disorder
  6. Extrapyramidal disorder
  7. Fatigue
  8. Headache
  9. Iron deficiency anaemia
  10. Musculoskeletal stiffness

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Ranexa?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Sumatriptan and Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sumatriptan interactions:

Browse all interactions between Sumatriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ranexa interactions:

Browse all interactions between Ranexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and ranolazine (the active ingredients of Sumatriptan and Ranexa, respectively), and Sumatriptan and Ranexa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Sumatriptan and Ranexa.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: